Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Lab Equipment

    MJFF Announces Six New Funding Programs Now Accepting Applications

    The Foundation has launched six new RFAs for 2021 research support.
    Learn more

  • Ask the PhD: LRRK2 Research Forges Ahead

    In our latest Ask the PhD video, MJFF staff scientist Dr. Marco Baptista talks about recent progress in LRRK2 research.
    Learn more

  • Doctor Equipment

    News in Context: LRRK2 Therapies Speeding Forward after $1B Biotech Deal

    This partnership speeding therapeutic testing is built on work from The Michael J. Fox Foundation de-risking LRRK2 drug development and supporting measurement tools.
    Learn more

  • On Laptop

    Don’t Miss MJFF’s New Webinar Series on Parkinson’s R&D

    Thanks to all of you — our moderators, panelists, viewers and sponsors — the new Parkinson's Disease Therapeutics Webinars series is already a success.
    Learn more

  • Ken Griffin Alpha-Synuclein Imaging Competition

    Three Teams Win the “Ken Griffin Alpha-synuclein Imaging Competition”  

    Three teams will pursue unique approaches to develop this game-changing research tool.
    Learn more

  • PET-CT.jpg

    Research Perspective: Alpha-Synuclein Imaging

    Over the last 10 years, researchers have made impressive strides in the development of an alpha-synuclein imaging agent.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.